Literature DB >> 1592489

Mechanisms of endothelial cell-dependent leukocyte adhesion stimulated by platelet-activating factor.

Z Ding1, S Li, Z Wu.   

Abstract

Platelet-activating factor (PAF) stimulates leukocyte-endothelial cell (EC) adhesion through its effects either on leukocytes or on ECs. ECs may be injured, synthesize, or express new adhesive proteins to increase leukocyte adhesion. Intermediary mediators produced by activated ECs are also likely involved in promoting leukocyte adhesion. Our experiments demonstrated that PAF induced no obvious damage to bovine pulmonary artery ECs evaluated by lactic dehydrogenase release rate, angiotensin-converting enzyme activity, and cellular malondialdehyde content. Treatment of EC monolayers with 10(-9) M PAF increased polymorphonuclear leukocyte (PMN) adhesion. Increasing PAF concentration did not induce more PMN adherence. PAF elicited both a rapid and prolonged increment of PMN adherence to EC monolayers. The rapid adherence was greatly attenuated by pretreatment of ECs with PAF receptor antagonist SRI 63-441 but was not affected by pretreatment of PMNs with SRI 63-441, suggesting that PAF increases PMN adherence rapidly through its effects on specific receptors on ECs. Increased PMN adherence lasted if PAF treatment of ECs was sustained for 3 or 6 h. Pretreatment of ECs with actinomycin D, a protein synthesis inhibitor, significantly decreased PAF-induced sustained PMN adherence, but the inhibition is incomplete, suggesting that other mechanisms than protein synthesis also participated in the prolonged PMN adherence. We concluded from the results that PAF may induce both rapid and prolonged PMN adhesion to ECs. The effects are receptor mediated. The prolonged PMN adhesion is partly the result of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592489     DOI: 10.1007/bf00918957

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

1.  Effect of platelet activating factor on leukocyte-endothelial cell interactions.

Authors:  J G Garcia; A Azghani; K S Callahan; A R Johnson
Journal:  Thromb Res       Date:  1988-07-01       Impact factor: 3.944

2.  Platelet-activating factor increases lung vascular permeability to protein.

Authors:  K E Burhop; J G Garcia; W M Selig; S K Lo; H van der Zee; J E Kaplan; A B Malik
Journal:  J Appl Physiol (1985)       Date:  1986-12

Review 3.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

4.  American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity.

Authors:  R S Cotran
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

5.  Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.

Authors:  F Bussolino; G Camussi; M Aglietta; P Braquet; A Bosia; G Pescarmona; F Sanavio; N D'Urso; P C Marchisio
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140.

Authors:  R Hattori; K K Hamilton; R D Fugate; R P McEver; P J Sims
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

7.  Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family.

Authors:  M G Tonnesen; D C Anderson; T A Springer; A Knedler; N Avdi; P M Henson
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

Authors:  J O Shaw; R N Pinckard; K S Ferrigni; L M McManus; D J Hanahan
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro.

Authors:  G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.

Authors:  G A Zimmerman; T M McIntyre; M Mehra; S M Prescott
Journal:  J Cell Biol       Date:  1990-02       Impact factor: 10.539

View more
  4 in total

1.  Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro.

Authors:  A Sterner-Kock; R K Braun; M D Schrenzel; D M Hyde
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

2.  Vascular barrier-enhancing effect of an endogenous beta-adrenergic agonist.

Authors:  Z Ding; M Jiang; S Li; Y Zhang
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

3.  Suppression by isoproterenol of endothelial cell morphology and barrier function changes induced by platelet-activating factor.

Authors:  Z Ding; S Li; M Jiang; Z Wu
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

4.  The effects of platelet activating factor and retinoic acid on the expression of ELAM-1 and ICAM-1 and the functions of neutrophils.

Authors:  S F Chen
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.